Sort
10,766 grants matching “checkpoint inhibitor”
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
$398,271Ryan J Sullivan · Massachusetts General Hospital · R01 · FY2018 · CA
Development of a small-molecule immunomodulator for the treatment of melanoma
$398,242Rukiyah Van Dross · Claradele Pharmaceuticals, Inc. · R41 · FY2022 · CA
A novel more effective genotoxic therapy for ovarian cancer
$398,125Fiona Simpkins · University Of Pennsylvania · R37 · FY2023 · CA
Development of first-in-class antagonists of the retinoid pathway as novel oral immunotherapies for solid cancers
$398,040Mark Esposito · Kayothera Inc. · R43 · FY2023 · CA
Development of Novel CD180-Based Cancer Immunotherapeutics
$398,040Edward A Clark · Abacus Bioscience Inc · R41 · FY2022 · CA
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
$398,040Michael T Barrett · Binary Genomics, Inc. · R43 · FY2023 · CA
Development of Localized Triple-Negative Breast Cancer Immunotherapy
$398,039David Zaharoff · Intra Therapeutics, Llc · R41 · FY2025 · CA
Implications of the ATR Checkpoint Kinase in Radiation and Targeted Therapies
$398,025Lee Zou · Massachusetts General Hospital · R01 · FY2015 · CA
Implications of the ATR Checkpoint Kinase in Radiation and Targeted Therapies
$398,025Lee Zou · Massachusetts General Hospital · R01 · FY2017 · CA
Implications of the ATR Checkpoint Kinase in Radiation and Targeted Therapies
$398,025Lee Zou · Massachusetts General Hospital · R01 · FY2018 · CA
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
$398,001Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Vaccine strategies for HIVAIDS
$397,966Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Regulation of Zbtb44-Eomes complex in CD8+T cells and anti-tumor immunity
$397,780Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2025 · AI
Effects of ATR-CHK1 inhibition on genome stability and cancer progression
$397,683Eric J Brown · University Of Pennsylvania · R01 · FY2015 · CA
Targeting the MET Pathway in Urothelial Carcinoma
$397,679Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Regulation of T cell maturation
$397,500Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2017 · AI
Regulation of T cell maturation
$397,500Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2019 · AI
Regulation of T cell maturation
$397,500Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2018 · AI
Regulation of T cell maturation
$397,500Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2015 · AI
Regulation of T cell maturation
$397,500Virginia Smith Shapiro · Mayo Clinic Rochester · R01 · FY2016 · AI
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
$397,373Cun-Yu Wang · University Of California Los Angeles · R01 · FY2021 · DE
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
$397,371Cun-Yu Wang · University Of California Los Angeles · R01 · FY2023 · DE
Role of Meis1 in Regulation of Cardiomyocyte Proliferation
$397,291Hesham Sadek · Ut Southwestern Medical Center · R01 · FY2012 · HL
Mechanisms of liver metastasis and associated resistance to immunotherapy
$397,013Benjamin Izar · Columbia University Health Sciences · R37 · FY2023 · CA
Analyzing DNA replication and damage vulnerability in IDH mutant glioma
$396,982Daniel P. Cahill · Massachusetts General Hospital · R01 · FY2024 · CA